| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
| filingDate |
2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102297440-B1 |
| titleOfInvention |
Chimeric antigens that specifically bind to target cells to enhance multiple immune function and uses thereof |
| abstract |
The present invention relates to a chimeric antigen for which multiple immune functions are enhanced by specific binding to a target cell and uses thereof. Specifically, the present invention provides enhanced multiple immune functions in which an immune response inducing region and a target cell specific binding inducing region are fused. chimeric antigen; a pharmaceutical composition for the prevention or treatment of cancer comprising the multi-immune-enhanced chimeric antigen as an active ingredient; a pharmaceutical composition for preventing or treating an infectious disease; adjuvant composition; and vaccine compositions. |
| priorityDate |
2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |